The Asia Pacific Veterinary Diagnostics Market would witness market growth of 11.6% CAGR during the forecast period (2023-2030).
The market refers to the industry focused on developing, producing, and distributing diagnostic tests, instruments, and services used to diagnose and monitor diseases in animals, primarily pets and livestock. Veterinary diagnostics are crucial in maintaining animal health, ensuring food safety, and controlling the spread of contagious diseases among animals. This category encompasses a wide range of tests and assays used to detect and identify various animal diseases and conditions. Examples include blood tests, urine tests, molecular diagnostics (such as PCR), serological tests, and imaging techniques (X-rays, ultrasound, MRI).
Manufacturers produce specialized diagnostic instruments and equipment used by veterinarians and laboratories. These may include blood analyzers, microscopes, centrifuges, and imaging devices. Reagents and consumables are essential supplies used in diagnostic tests. These include test kits, reagents, culture media, and other materials necessary for conducting tests accurately. Software plays an increasingly important role in veterinary diagnostics, helping with data analysis, reporting, and the management of diagnostic information. Electronic health records (EHRs) and laboratory information management systems (LIMS) are examples of such software.
Asia Pacific (APAC) region was experiencing significant growth and presented several trends and factors contributing to this expansion. The rising middle-class population in many APAC countries has increased pet ownership, particularly of dogs and cats. As pet owners seek better healthcare for their animals, the demand has grown. According to the Government of India report Comparative Statement for Export of Agri and Processed Food Products, in 2022-23, the number of livestock products is 1428 USD million. Therefore, the growth of this market will boost in this region because of the aforementioned factors.
The China market dominated the Asia Pacific Veterinary Diagnostics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.0 billion by 2030. The Japan market is estimated to witness a CAGR of 10.9% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 12.2% during (2023 - 2030).
Based on Product, the market is segmented into Consumables, Reagents & Kits, Instruments & Devices. Based on End Use, the market is segmented into Laboratories, Veterinary Hospitals & Clinics, Point-Of-Care/In-House Testing, Research Institutes & Universities. Based on Disease Type, the market is segmented into Non-Infectious Diseases, General Ailments, Infectious Diseases, Hereditary, Congenital & Acquired Diseases, and Others. Based on Testing Type, the market is segmented into Pathology, Bacteriology & Molecular Diagnostics, Diagnostic Imaging, Immunoassays, Parasitology, Serology & Virology and Analytical Services. Based on Species, the market is segmented into Canine, Avian, Ovine, Equine, Cattle, Caprine, Feline, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Veterinary Diagnostics Market is Projected to reach USD 15.6 Billion by 2030, at a CAGR of 10.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Heska Corporation (Antech Diagnostics, Inc), IDEXX Laboratories Inc., Agrolabo S.p.A., Innovative Diagnostics SAS (Idvet), Virbac, Thermo Fisher Scientific, Inc., Neogen Corporation, Covetrus, Inc. (Clayton, Dubilier & Rice, LLC), and iM3 Pty Ltd
By Product
By End Use
By Disease Type
By Testing Type
By Species
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
